Volume 381, Issue 9872, Pages (March 2013)

Slides:

Advertisements

Similar presentations

WOEST ESC, Hotline III, Munchen, August 28th, 2012

Advertisements

¨ 8 European countries, 48 centres Stent implantation Double-blind randomisation n = 1005 Clopidogrel 300mg od Aspirin 325mg od Clopidogrel 75mg od Aspirin.

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship between heparin anticoagulation and.

Volume 389, Issue 10081, Pages (May 2017)

Volume 370, Issue 9586, Pages (August 2007)

Volume 386, Issue 10006, Pages (November 2015)

Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double- blind placebo-controlled trial Patricia van Velzen, MD, Gerben ter.

Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.

Volume 379, Issue 9824, Pages (April 2012)

Volume 352, Issue 9131, Pages (September 1998)

Volume 9, Issue 3, Pages (March 2010)

Volume 357, Issue 9273, Pages (June 2001)

Volume 364, Issue 9440, Pages (September 2004)

Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled.

American Heart Journal

Volume 351, Issue 9110, Pages (April 1998)

Volume 357, Issue 9257, Pages (March 2001)

Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international,

Volume 349, Issue 9057, Pages (April 1997)

Influence of Diabetes Mellitus on Clinical Outcomes Following Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial.

Volume 385, Issue 9985, Pages (June 2015)

Volume 8, Issue 10, Pages (October 2009)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Volume 16, Issue 9, Pages (September 2015)

Volume 376, Issue 9734, Pages (July 2010)

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after.

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

Volume 384, Issue 9957, Pages (November 2014)

Volume 11, Issue 6, Pages (June 2012)

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation.

Volume 371, Issue 9611, Pages (February 2008)

Volume 376, Issue 9734, Pages (July 2010)

Volume 392, Issue 10145, Pages (August 2018)

Long-term effects of hormone replacement therapy

Volume 385, Issue 9967, Pages (February 2015)

Volume 12, Issue 9, Pages (September 2013)

Volume 1, Issue 3, Pages (August 2014)

Volume 373, Issue 9677, Pages (May 2009)

Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)

Aspirin in the prevention of cancer – Author's reply

Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Volume 372, Issue 9642, Pages (September 2008)

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction P.-G. Chassot, A. Delabays, D.R. Spahn

NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.

Volume 384, Issue 9957, Pages (November 2014)

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,

Volume 9, Issue 9, Pages (September 2010)

Volume 379, Issue 9821, Pages (March 2012)

Volume 379, Issue 9812, Pages (January 2012)

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.

Volume 385, Issue 9985, Pages (June 2015)

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 371, Issue 9627, Pages (May 2008)

Volume 378, Issue 9786, Pages (July 2011)

Thank God for Richard Dawkins?

Department of Error The Lancet Volume 369, Issue 9564, (March 2007)

Volume 375, Issue 9719, Pages (March 2010)

Volume 375, Issue 9714, Pages (February 2010)

Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction Salman A. Haq, MD, John F. Heitner, MD, Terrence J.

Volume 5, Issue 1, Pages (January 2018)

ECASS-II: intravenous alteplase in acute ischaemic stroke

Volume 383, Issue 9930, Pages (May 2014)

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Volume 371, Issue 9611, Pages (February 2008)

Presentation transcript:

Volume 381, Issue 9872, Pages 1107-1115 (March 2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Dr Willem JM Dewilde, MD, Tom Oirbans, MSc, Prof Freek WA Verheugt, MD, Johannes C Kelder, MD, Bart JGL De Smet, MD, Jean- Paul Herrman, MD, Tom Adriaenssens, MD, Mathias Vrolix, MD, Antonius ACM Heestermans, MD, Marije M Vis, MD, Prof Jan GP Tijsen, MD, Arnoud W van 't Hof, MD, Jurriën M ten Berg, MD The Lancet Volume 381, Issue 9872, Pages 1107-1115 (March 2013) DOI: 10.1016/S0140-6736(12)62177-1 Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile PCI=percutaneous coronary intervention. *Two patients in the double-therapy group and one in the triple-therapy group were included in the intention-to-treat analysis until the day of withdrawal. The Lancet 2013 381, 1107-1115DOI: (10.1016/S0140-6736(12)62177-1) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Incidence of the primary endpoint (any bleeding) HR=hazard ratio. The Lancet 2013 381, 1107-1115DOI: (10.1016/S0140-6736(12)62177-1) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 Cumulative incidence of the secondary endpoint (death, myocardial infarction, stroke, target-vessel revascularisation, and stent thrombosis) HR=hazard ratio. The Lancet 2013 381, 1107-1115DOI: (10.1016/S0140-6736(12)62177-1) Copyright © 2013 Elsevier Ltd Terms and Conditions